Paul J Keall1, Jin Aun Ng2, Prabhjot Juneja3, Ricky T O'Brien2, Chen-Yu Huang2, Emma Colvill3, Vincent Caillet3, Emma Simpson4, Per R Poulsen5, Andrew Kneebone3, Thomas Eade3, Jeremy T Booth3. 1. Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia. Electronic address: paul.keall@sydney.edu.au. 2. Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia. 3. Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia; Northern Sydney Cancer Centre, Sydney, New South Wales, Australia. 4. Northern Sydney Cancer Centre, Sydney, New South Wales, Australia. 5. Aarhus University Hospital, Aarhus, Denmark.
Abstract
PURPOSE: Kilovoltage intrafraction monitoring (KIM) is a new real-time 3-dimensional image guidance method. Unlike previous real-time image guidance methods, KIM uses a standard linear accelerator without any additional equipment needed. The first prospective clinical trial of KIM is underway for prostate cancer radiation therapy. In this paper we report on the measured motion accuracy and precision using real-time KIM-guided gating. METHODS AND MATERIALS: Imaging and motion information from the first 200 fractions from 6 patient prostate cancer radiation therapy volumetric modulated arc therapy treatments were analyzed. A 3-mm/5-second action threshold was used to trigger a gating event where the beam is paused and the couch position adjusted to realign the prostate to the treatment isocenter. To quantify the in vivo accuracy and precision, KIM was compared with simultaneously acquired kV/MV triangulation for 187 fractions. RESULTS: KIM was successfully used in 197 of 200 fractions. Gating events occurred in 29 fractions (14.5%). In these 29 fractions, the percentage of beam-on time, the prostate displacement was >3 mm from the isocenter position, reduced from 73% without KIM to 24% with KIM-guided gating. Displacements >5 mm were reduced from 16% without KIM to 0% with KIM. The KIM accuracy was measured at <0.3 mm in all 3 dimensions. The KIM precision was <0.6 mm in all 3 dimensions. CONCLUSIONS: Clinical implementation of real-time KIM image guidance combined with gating for prostate cancer eliminates large prostate displacements during treatment delivery. Both in vivo KIM accuracy and precision are well below 1 mm.
PURPOSE: Kilovoltage intrafraction monitoring (KIM) is a new real-time 3-dimensional image guidance method. Unlike previous real-time image guidance methods, KIM uses a standard linear accelerator without any additional equipment needed. The first prospective clinical trial of KIM is underway for prostate cancer radiation therapy. In this paper we report on the measured motion accuracy and precision using real-time KIM-guided gating. METHODS AND MATERIALS: Imaging and motion information from the first 200 fractions from 6 patientprostate cancer radiation therapy volumetric modulated arc therapy treatments were analyzed. A 3-mm/5-second action threshold was used to trigger a gating event where the beam is paused and the couch position adjusted to realign the prostate to the treatment isocenter. To quantify the in vivo accuracy and precision, KIM was compared with simultaneously acquired kV/MV triangulation for 187 fractions. RESULTS: KIM was successfully used in 197 of 200 fractions. Gating events occurred in 29 fractions (14.5%). In these 29 fractions, the percentage of beam-on time, the prostate displacement was >3 mm from the isocenter position, reduced from 73% without KIM to 24% with KIM-guided gating. Displacements >5 mm were reduced from 16% without KIM to 0% with KIM. The KIM accuracy was measured at <0.3 mm in all 3 dimensions. The KIM precision was <0.6 mm in all 3 dimensions. CONCLUSIONS: Clinical implementation of real-time KIM image guidance combined with gating for prostate cancer eliminates large prostate displacements during treatment delivery. Both in vivo KIM accuracy and precision are well below 1 mm.
Authors: Paul J Keall; Doan Trang Nguyen; Ricky O'Brien; Pengpeng Zhang; Laura Happersett; Jenny Bertholet; Per R Poulsen Journal: Int J Radiat Oncol Biol Phys Date: 2018-04-14 Impact factor: 7.038
Authors: Lee Wilton; Matthew Richardson; Sarah Keats; Kimberley Legge; Mary-Claire Hanlon; Sankar Arumugam; Perry Hunter; Tiffany-Jane Evans; Mark Sidhom; Jarad Martin Journal: J Med Radiat Sci Date: 2017-08-08
Authors: Paul Keall; Doan Trang Nguyen; Ricky O'Brien; Jeremy Booth; Peter Greer; Per Poulsen; Val Gebski; Andrew Kneebone; Jarad Martin Journal: BMC Cancer Date: 2017-03-08 Impact factor: 4.430
Authors: Casper Gammelmark Muurholm; Thomas Ravkilde; Robin De Roover; Simon Skouboe; Rune Hansen; Wouter Crijns; Tom Depuydt; Per R Poulsen Journal: Med Phys Date: 2022-04-25 Impact factor: 4.506
Authors: Kimberley Legge; Doan Nguyen; Jin Aun Ng; Lee Wilton; Matthew Richardson; Jeremy Booth; Paul Keall; Darryl J O'Connor; Peter Greer; Jarad Martin Journal: J Appl Clin Med Phys Date: 2017-09-27 Impact factor: 2.102
Authors: Thomas Eade; George Hruby; Jeremy Booth; Regina Bromley; Lesley Guo; Andrew O'Toole; Andrew Le; Kenny Wu; May Whitaker; Krishan Rasiah; Venu Chalasani; Justin Vass; Carolyn Kwong; John Atyeo; Andrew Kneebone Journal: Adv Radiat Oncol Date: 2019-04-11